- What we offer
- Co-investment facilities
- Project loans
- Intermediated loans
- Looking for an SME loan?
- Venture capital
- Venture debt
- Equity and fund investments
- Infrastructure equity funds
- Infrastructure debt funds
- Environmental funds
- Equity funds in the ACP regions
- Equity funds in the Mediterranean region
- Structured finance
- Project bonds
- InnovFin – EU Finance for innovators
- How to apply
- Donor partnerships
- Trust funds
- Transport infrastructure
- JEREMIE: Flexible SME funding
- ESIF Financial Instruments
- Financial Instruments in practice
- ESIF FIs in 2014-2020
- EIB role in Financial Instruments in 2014-2020
- Calls for expression of interest
- Mutual Reliance Initiative
- Private Finance for Energy Efficiency (PF4EE)
- Natural Capital Financing Facility
- In a nutshell
- Project examples
- Technical assistance
- NCFF - Cities
- Risk Capital Facility for the Southern Neighbourhood
- EU Trade and Competitiveness Programme in Egypt, Jordan, Morocco and Tunisia
- EU Blending facilities
- InnovFin advisory
- EPEC / Public-Private Partnerships (PPPs)
- ELENA – European Local ENergy Assistance
- On-going projects
- Completed projects
- FELICITY: Sustainable solutions for cities
- MPSF - Municipal Project Support Facility
- Investments in SME and mid-cap funds
- Investments in infrastructure and environmental funds
InnovFin – EU Finance for innovators
Whether you are a small and medium sized enterprise (SME), a large company or a research institution, InnovFin can provide the right financing instrument for your research and innovation project.
What financing products are available?
InnovFin financing tools cover a wide range of loans, guarantees and equity-type funding, which can be tailored to innovators’ needs. Financing is either provided directly or via a financial intermediary, most usually a bank or a fund.
To read more about which InnovFin products are available and who can benefit from them, please click here.
What are the objectives of InnovFin?
InnovFin aims to facilitate and accelerate access to finance for innovative businesses and other innovative entities in Europe.
One of the key factors constraining the implementation of R&I activities is the lack of available financing at acceptable terms to innovative businesses since these types of companies or projects deal with complex products and technologies, unproven markets and intangible assets.
In order to overcome these difficulties, the EU and the EIB Group have joined forces to provide finance for research and innovation to entities that may otherwise struggle to access financing.
Why are the EU and EIB Group supporting innovative companies?
The EU lags behind its global competitors in terms of both private and public investment in research and innovation.
However, innovation is a key ingredient for driving sustainable growth, creating jobs and ensuring Europe’s long-term competitiveness. That is why the EIB Group and the European Commission have made it a top priority to facilitate access to finance for innovative businesses in Europe.
What is new about InnovFin?
InnovFin builds on the success of the former Risk-Sharing Finance Facility developed in the early 2000’s under the EU framework programme for research and technological development (FP7).
Under the 2014-2020 programming period, the European Union and EIB Group have more than doubled their combined support for innovative firms in Europe. In addition to more financing being made available, InnovFin also offers a greater product range.
InnovFin has been developed in such a way to provide a series of integrated and complementary financing tools.
The InnovFin products are subject to regular updates to reflect market evolution. Since its launch in 2014, a dozen products have been tailored and made available to accommodate niche markets previously suffering from access to finance gaps and to reinforce the complementarity with the European Fund for Strategic Investments (EFSI).
- 3 new ways to treat cancer
- A jolt of green energy for Europe
- Molecular diagnostics save lives and money
- Zika vaccine: microbes to save babies
- Medical innovation: How a 2-year-old’s pain led to a big idea
- Solar energy innovation: Buildings get a skin that generates clean energy
- Quasi-equity: A new financial structure for a new challenge
- Qwant did you say?